Matches in SemOpenAlex for { <https://semopenalex.org/work/W2147111737> ?p ?o ?g. }
- W2147111737 endingPage "5" @default.
- W2147111737 startingPage "5" @default.
- W2147111737 abstract "Vitamin K Antagonists (VKAs) are widely used in clinical practice and nearly 1% of the entire population receives oral anticoagulation at least once in life. However, the rate of prescription of anticoagulation is low, compared to what it should be. No more than 50-60% of patients affected by atrial fibrillation (AF) receive anticoagulation. In the setting of AF, VKAs are safe and effective when properly managed, reducing stroke and systemic embolism by more than 60%. VKAs safety and effectiveness are closely related to the quality of anticoagulation (e.g. time in therapeutic range), and anticoagulation clinics offer the best management of anticoagulant therapy. However, a sizeable proportion of patients are managed elsewhere. In clinical practice, in the setting of AF, a low prescription rate of VKAs is frequently observed and this is due also to difficulties in managing laboratory monitoring and drug dose adjustment. The suboptimal management of therapy with VKAs leads to a lesser efficacy than that reported in clinical trials, and to an increase in adverse reactions. VKAs still remain the first and only available therapy for a number of diseases (e.g. valvular atrial fibrillation and mechanical prosthetic heart valves). Now, since approval of the new oral anticoagulants (NOAs), the choice of anticoagulant therapy in definite settings, such as stroke prevention in non-valvular atrial fibrillation (SPAF) or treatment of venous thromboembolism, has surely become more intriguing but also more problematic. In light of these new therapeutic options, we reviewed VKAs therapy, in the setting of atrial fibrillation, focusing on VKAs impact in real life. We analyzed the data about efficacy and safety of warfarin at three levels: clinical trial and real life, outside and inside anticoagulation clinics." @default.
- W2147111737 created "2016-06-24" @default.
- W2147111737 creator A5014145518 @default.
- W2147111737 creator A5039199126 @default.
- W2147111737 date "2014-01-01" @default.
- W2147111737 modified "2023-10-18" @default.
- W2147111737 title "Warfarin and atrial fibrillation: from ideal to real the warfarin affaire" @default.
- W2147111737 cites W1490007665 @default.
- W2147111737 cites W159232318 @default.
- W2147111737 cites W1967046500 @default.
- W2147111737 cites W1982179895 @default.
- W2147111737 cites W1999468381 @default.
- W2147111737 cites W2023003374 @default.
- W2147111737 cites W2023487444 @default.
- W2147111737 cites W2024301885 @default.
- W2147111737 cites W2059533196 @default.
- W2147111737 cites W2066098573 @default.
- W2147111737 cites W2073500756 @default.
- W2147111737 cites W2084929494 @default.
- W2147111737 cites W2088052643 @default.
- W2147111737 cites W2089534375 @default.
- W2147111737 cites W2090225839 @default.
- W2147111737 cites W2095647706 @default.
- W2147111737 cites W2096721022 @default.
- W2147111737 cites W2097854437 @default.
- W2147111737 cites W2103053426 @default.
- W2147111737 cites W2121403509 @default.
- W2147111737 cites W2129962350 @default.
- W2147111737 cites W2132939786 @default.
- W2147111737 cites W2136489990 @default.
- W2147111737 cites W2137684106 @default.
- W2147111737 cites W2144582288 @default.
- W2147111737 cites W2150666115 @default.
- W2147111737 cites W2156687558 @default.
- W2147111737 cites W2159730165 @default.
- W2147111737 cites W2162508946 @default.
- W2147111737 cites W2165340895 @default.
- W2147111737 cites W2170845996 @default.
- W2147111737 cites W2314496365 @default.
- W2147111737 cites W2316604591 @default.
- W2147111737 doi "https://doi.org/10.1186/1477-9560-12-5" @default.
- W2147111737 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3937065" @default.
- W2147111737 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24548437" @default.
- W2147111737 hasPublicationYear "2014" @default.
- W2147111737 type Work @default.
- W2147111737 sameAs 2147111737 @default.
- W2147111737 citedByCount "36" @default.
- W2147111737 countsByYear W21471117372015 @default.
- W2147111737 countsByYear W21471117372016 @default.
- W2147111737 countsByYear W21471117372017 @default.
- W2147111737 countsByYear W21471117372018 @default.
- W2147111737 countsByYear W21471117372019 @default.
- W2147111737 countsByYear W21471117372020 @default.
- W2147111737 countsByYear W21471117372021 @default.
- W2147111737 countsByYear W21471117372022 @default.
- W2147111737 countsByYear W21471117372023 @default.
- W2147111737 crossrefType "journal-article" @default.
- W2147111737 hasAuthorship W2147111737A5014145518 @default.
- W2147111737 hasAuthorship W2147111737A5039199126 @default.
- W2147111737 hasBestOaLocation W21471117371 @default.
- W2147111737 hasConcept C126322002 @default.
- W2147111737 hasConcept C127413603 @default.
- W2147111737 hasConcept C164705383 @default.
- W2147111737 hasConcept C177713679 @default.
- W2147111737 hasConcept C2426938 @default.
- W2147111737 hasConcept C2776301958 @default.
- W2147111737 hasConcept C2779161974 @default.
- W2147111737 hasConcept C2780645631 @default.
- W2147111737 hasConcept C2780971015 @default.
- W2147111737 hasConcept C2908647359 @default.
- W2147111737 hasConcept C71924100 @default.
- W2147111737 hasConcept C78519656 @default.
- W2147111737 hasConcept C98274493 @default.
- W2147111737 hasConcept C99454951 @default.
- W2147111737 hasConceptScore W2147111737C126322002 @default.
- W2147111737 hasConceptScore W2147111737C127413603 @default.
- W2147111737 hasConceptScore W2147111737C164705383 @default.
- W2147111737 hasConceptScore W2147111737C177713679 @default.
- W2147111737 hasConceptScore W2147111737C2426938 @default.
- W2147111737 hasConceptScore W2147111737C2776301958 @default.
- W2147111737 hasConceptScore W2147111737C2779161974 @default.
- W2147111737 hasConceptScore W2147111737C2780645631 @default.
- W2147111737 hasConceptScore W2147111737C2780971015 @default.
- W2147111737 hasConceptScore W2147111737C2908647359 @default.
- W2147111737 hasConceptScore W2147111737C71924100 @default.
- W2147111737 hasConceptScore W2147111737C78519656 @default.
- W2147111737 hasConceptScore W2147111737C98274493 @default.
- W2147111737 hasConceptScore W2147111737C99454951 @default.
- W2147111737 hasIssue "1" @default.
- W2147111737 hasLocation W21471117371 @default.
- W2147111737 hasLocation W21471117372 @default.
- W2147111737 hasLocation W21471117373 @default.
- W2147111737 hasLocation W21471117374 @default.
- W2147111737 hasOpenAccess W2147111737 @default.
- W2147111737 hasPrimaryLocation W21471117371 @default.
- W2147111737 hasRelatedWork W131995492 @default.
- W2147111737 hasRelatedWork W1997300706 @default.
- W2147111737 hasRelatedWork W2062685615 @default.